guest ::
| Home > Publications database > SRSF2 safeguards efficient transcription of DNA damage and repair genes. > print |
| Home > Publications database > SRSF2 safeguards efficient transcription of DNA damage and repair genes. > print |
| 001 | 294321 | ||
| 005 | 20250220163815.0 | ||
| 024 | 7 | _ | |a 10.1016/j.celrep.2024.114869 |2 doi |
| 024 | 7 | _ | |a pmid:39446588 |2 pmid |
| 024 | 7 | _ | |a 2211-1247 |2 ISSN |
| 024 | 7 | _ | |a 2639-1856 |2 ISSN |
| 024 | 7 | _ | |a altmetric:169729140 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2024-02154 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Wagner, Rebecca |0 P:(DE-He78)3ffdda266b4958f6a267fa2ce18f2762 |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a SRSF2 safeguards efficient transcription of DNA damage and repair genes. |
| 260 | _ | _ | |a [New York, NY] |c 2024 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1730124566_10605 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A350#LA:A350# |
| 520 | _ | _ | |a The serine-/arginine-rich splicing factor 2 (SRSF2) plays pivotal roles in pre-mRNA processing and gene transcription. Recurrent mutations, particularly a proline-to-histidine substitution at position 95 (P95H), are common in neoplastic diseases. Here, we assess SRSF2's diverse functions in squamous cell carcinoma. We show that SRSF2 deletion or homozygous P95H mutation both cause extensive DNA damage leading to cell-cycle arrest. Mechanistically, SRSF2 regulates efficient bi-directional transcription of DNA replication and repair genes, independent from its function in splicing. Further, SRSF2 haploinsufficiency induces DNA damage without halting the cell cycle. Exposing mouse skin to tumor-promoting carcinogens enhances the clonal expansion of heterozygous Srsf2 P95H epidermal cells but unexpectedly inhibits tumor formation. To survive carcinogen treatment, Srsf2 P95H+/- cells undergo substantial transcriptional rewiring and restore bi-directional gene expression. Thus, our study underscores SRSF2's importance in regulating transcription to orchestrate the cell cycle and the DNA damage response. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a CP: Cancer |2 Other |
| 650 | _ | 7 | |a CP: Molecular biology |2 Other |
| 650 | _ | 7 | |a DNA damage |2 Other |
| 650 | _ | 7 | |a DNA repair |2 Other |
| 650 | _ | 7 | |a DNA replication |2 Other |
| 650 | _ | 7 | |a Transcription |2 Other |
| 650 | _ | 7 | |a bi-directional promoters |2 Other |
| 650 | _ | 7 | |a epithelia |2 Other |
| 650 | _ | 7 | |a skin |2 Other |
| 700 | 1 | _ | |a Arnetzl, Leonie |0 P:(DE-He78)28c65fbc14e7fbd94cbb331f9b7025d9 |b 1 |
| 700 | 1 | _ | |a Britto-Borges, Thiago |b 2 |
| 700 | 1 | _ | |a Heit-Mondrzyk, Anke |0 P:(DE-He78)a3d2e48d4d32d6b3952996020fe8d1b5 |b 3 |u dkfz |
| 700 | 1 | _ | |a Bakr, Ali |0 P:(DE-He78)277add45f831355e9453b41e651f6411 |b 4 |u dkfz |
| 700 | 1 | _ | |a Sollier, Etienne |0 P:(DE-He78)690891e88caacd9f6327522d7d167149 |b 5 |u dkfz |
| 700 | 1 | _ | |a Gkatza, Nikoletta A |b 6 |
| 700 | 1 | _ | |a Panten, Jasper |0 P:(DE-He78)d4405881b542f40197770d457d737895 |b 7 |u dkfz |
| 700 | 1 | _ | |a Delaunay, Sylvain |0 P:(DE-He78)7db81e03313a2df5e17380868363a0d8 |b 8 |u dkfz |
| 700 | 1 | _ | |a Sohn, Daniela |0 P:(DE-He78)bdd027a3817257abc3d945ab048d2ab3 |b 9 |u dkfz |
| 700 | 1 | _ | |a Schmezer, Peter |0 P:(DE-He78)141ce740f5d881812d2675147b72ecaf |b 10 |
| 700 | 1 | _ | |a Odom, Duncan T |0 P:(DE-He78)4c21317940f3ec566480ebcdcff3e00c |b 11 |u dkfz |
| 700 | 1 | _ | |a Müller-Decker, Karin |0 P:(DE-He78)799d978330dff449f8244947929a4518 |b 12 |
| 700 | 1 | _ | |a Plass, Christoph |0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |b 13 |u dkfz |
| 700 | 1 | _ | |a Dieterich, Christoph |b 14 |
| 700 | 1 | _ | |a Lutsik, Pavlo |0 P:(DE-He78)ff1677c63392be9b31a1c8d23db7c9dc |b 15 |u dkfz |
| 700 | 1 | _ | |a Bornelöv, Susanne |b 16 |
| 700 | 1 | _ | |a Frye, Michaela |0 P:(DE-He78)78bbb829c94caf04ce9b6fb4a5b13edc |b 17 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1016/j.celrep.2024.114869 |g Vol. 43, no. 11, p. 114869 - |0 PERI:(DE-600)2649101-1 |n 11 |p 114869 |t Cell reports |v 43 |y 2024 |x 2211-1247 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:294321 |p VDB |p OpenAPC |p openCost |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)3ffdda266b4958f6a267fa2ce18f2762 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)28c65fbc14e7fbd94cbb331f9b7025d9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)a3d2e48d4d32d6b3952996020fe8d1b5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)277add45f831355e9453b41e651f6411 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)690891e88caacd9f6327522d7d167149 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)d4405881b542f40197770d457d737895 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)7db81e03313a2df5e17380868363a0d8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)bdd027a3817257abc3d945ab048d2ab3 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)141ce740f5d881812d2675147b72ecaf |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)4c21317940f3ec566480ebcdcff3e00c |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)ff1677c63392be9b31a1c8d23db7c9dc |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)78bbb829c94caf04ce9b6fb4a5b13edc |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2024 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL REP : 2022 |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-02T08:49:39Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-02T08:49:39Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-05-02T08:49:39Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-26 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-26 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-26 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL REP : 2022 |d 2023-10-26 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-10-26 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-10-26 |
| 915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
| 915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
| 915 | p | c | |a DFG OA Publikationskosten |2 APC |0 PC:(DE-HGF)0002 |
| 915 | p | c | |a DEAL: Elsevier 09/01/2023 |2 APC |0 PC:(DE-HGF)0125 |
| 915 | p | c | |a DOAJ Journal |2 APC |0 PC:(DE-HGF)0003 |
| 920 | 2 | _ | |0 I:(DE-He78)A350-20160331 |k A350 |l A350 Reguläre Mechanismen der Genexpression |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A350-20160331 |k A350 |l A350 Reguläre Mechanismen der Genexpression |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B370-20160331 |k B370 |l Epigenomik |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)B270-20160331 |k B270 |l B270 Regulatorische Genomik und Evolution von Tumoren |x 2 |
| 920 | 0 | _ | |0 I:(DE-He78)A350-20160331 |k A350 |l A350 Reguläre Mechanismen der Genexpression |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A350-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B370-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B270-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a APC |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|